Oxyniff Nasal Drop contains Oxymetazoline 0.1% w/v, a nasal decongestant indicated for the relief of nasal congestion associated with allergic rhinitis, sinusitis, common cold, and other upper respiratory conditions. It helps in reducing nasal swelling and improving airflow for easier breathing.
Oxymetazoline works by stimulating alpha-adrenergic receptors in nasal mucosa, causing vasoconstriction of blood vessels and decreasing congestion. Its nasal drop formulation ensures rapid onset and targeted action.
For distributors and healthcare suppliers, Oxyniff Nasal Drop is a high-demand ENT therapy product, commonly used in hospitals, clinics, and general practice for both adults and pediatric patients. The prevalence of nasal congestion and rhinitis ensures continuous demand throughout the year.
Adding Oxyniff Nasal Drop to your nasal care and ENT therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its proven efficacy, fast-acting formulation, and prescriber trust make it a valuable addition to pharmaceutical distribution portfolios.